Nanopath is a molecular diagnostics company disrupting traditional testing methodologies. We aim to improve the health of women by providing granular and clinically actionable information within a single office visit.

At Nanopath, we are passionate about improving human health through the development of live-saving technologies. We founded our company because we believe that the technology we've developed in the lab can save lives.

Nanopath was spun out of the Thayer School of Engineering at Dartmouth in partnership with Dartmouth Hitchcock Medical Center.